Termination TerugBetaalRegeling Forxiga® - Hartfalen
From July 1st 2021 onwards, Forxiga® (dapagliflozine) 10 mg for the treatment of heart failure with reduced ejection fraction (HFrEF) is fully…
Amendment to TerugBetaalRegeling Lokelma®
TBR Nederland hereby informs you that it will make a change to a repayment scheme starting from now. This concerns the medicine Lokelma® 5g and 10g.
The…
Reimbursement Scheme FRAGMIN® 2500
The health insurer does not fully reimburse FRAGMIN® 2500. The producer of this medicine has therefore asked TBR Nederland to reimburse the costs of the…
Simplified TerugBetaalRegeling Broxil®
The health insurer will not reimburse the cost of Broxil® 125 mg / 5 mL, powder for oral suspension in full. The producer of this medicine has therefore…
General information
The pharmacist has dispensed Cresemba® 100mg to the patient. The health insurer will not reimburse the cost of this prescription in full. The producer of this medicine…
Reimbursement Scheme Forxiga® - Hartfalen
The health insurer does not yet fully reimburse Forxiga® (dapagliflozine) 10 mg for the treatment of symptomatic chronic heart failure with reduced ejection…
TBR Nederland is a unit of Phareso, acronym for PHArmaceutical REimbursement SOlutions. Phareso is an expert provider of state-of-the-art payment solutions. Phareso’s technology is used to…
View all the medicine news
View all the medicine news
View All
If you need any assistance please read our Frequently Asked Questions or contact our Servicedesk on info@tbrnederland.nl…
How does a family account work?
When you start claiming, first upload a copy of your health insurer’s overview/invoice from your pharmacy and then select for which family member you want to claim.…
Reimbursement Scheme Intuniv®
Intuniv’s medicine page has been updated. In the menu 'who can submit a claim' you can now read more about the declaration process of this Reimbursement…
